Acid Reflux Disease
November 3, 2017| Asthma/COPDDiabetesGastrointestinal DiseaseMedical Science
(Brand Option)
Select Quantity
$135.00
$336.00
$373.00
$159.00
$312.00
$450.00
(Generic Alternative)
Trelegy Ellipta is indicated as a maintenance treatment in adult patients with moderate to severe chronic obstructive pulmonary disease (COPD) who are not adequately treated by a combination of an inhaled corticosteroid (ICS) and a long-acting 2-agonist (LABA) or a combination of a long-acting muscarinic antagonist (LAMA) and a long-acting 2-agonist (LABA).
It is also indicated for the maintenance treatment of asthma in patients aged 18 years and older.
Trelegy Ellipta contains three active substances; an inhaled corticosteroid (fluticasone furoate) and two bronchodilators (umeclidinium and vilanterol).
Do’s
Don’ts
Common Side Effects:
Less Common, but more Serious Side Effects:
Serious Side Effects:
If you experience any of these side effects, seek medical attention.
Consult your healthcare provider for more information about the side effects of Trelegy Ellipta and discuss any concerns you may have.
Trelegy Ellipta should not be initiated in patients during rapidly deteriorating or potentially life-threatening episodes of COPD. It has not been studied in subjects with acutely deteriorating COPD and should not be used for the relief of acute symptoms, i.e., as rescue therapy for the treatment of acute episodes of bronchospasm.
Trelegy Ellipta can cause paradoxical bronchospasm. If this occurs, patients should discontinue Trelegy Ellipta and contact their healthcare provider right away.
Hypersensitivity reactions, including anaphylaxis, may occur after the administration of Trelegy Ellipta. Patients should discontinue Trelegy Ellipta if such reactions occur.
Long-term use of Trelegy Ellipta may lead to a reduction in bone mineral density. Patients should be monitored for this potential effect.
Patients with current viral, bacterial, parasitic, or fungal infections should inform their healthcare provider before using Trelegy Ellipta, as this medication can decrease the immune system's ability to fight an infection.
It's not known whether Trelegy Ellipta is safe to use during pregnancy or while breastfeeding. Patients should seek medical advice in these situations.
Generic name: | Fluticasone furoate/Umeclidinium Bromide/Vilanterol Trifenatate, Fluticasone Furoate/Umeclidinium Bromide/Vilanterol Trifenatate |
---|---|
Formulation: | Inhalation Powder |
Strength(s): | 100/62.5/25mcg, 200/62.5/25mcg |
Quantities Available: | 30, 30, 60, 90 |
Guiding you every step of the way, ensuring access to affordable medicines. Our customer service team is available seven days a week to answer any questions or to address any concerns you may have. Please give us a call at Doctor Solve on Monday to Friday from 6am-8pm PST, or Saturdays and Sundays from 7am-5pm PST.